Yale scientists traced gamma brain waves to thalamus-cortex interactions. The discovery could reveal how brain rhythms shape perception and disease.
For more than a century, scientists have observed rhythmic waves of synchronized neuronal activity in the brain. Now, for the first time, researchers at Yale University have pinpointed where a specific type of this activity—known as gamma waves—originates and have linked it directly to behavior.
Through the development of a highly precise new method for measuring brain activity, the team overcame long-standing technical barriers that had prevented a clear understanding of how these oscillations contribute to information processing and behavioral control.
The findings were recently published in the journal Nature.
Following an unexpected discovery
Jessica Cardin, PhD, the Gordon M. Shepherd Professor of Neuroscience at Yale School of Medicine and senior author of the study, did not initially plan to revisit this topic. As a postdoctoral researcher, she had previously shown that gamma waves could be artificially induced in the brain, but she considered the "perfect experiment" to test their function nearly impossible.
In neuroscience, determining the role of an element such as a gene, protein, or neural rhythm typically involves disrupting it to observe the consequences. However, that approach does not work for brain oscillations.

That changed when one of her postdoctoral fellows, Quentin Perrenoud, PhD—the study's first author—presented intriguing data he had gathered while tracking how information moved through the brain during a behavioral task. The results suggested that gamma waves might be predicting behavior. Encouraged by the evidence, the team pursued the lead, ultimately uncovering findings that challenge long-held assumptions about how these brain rhythms arise.
"It's not quite a perfect experiment, but it's a lot closer to a perfect experiment than we've ever been able to get," says Cardin.
Gamma activity emerges from interactions between the thalamus and cortex
To carry out the study, the research team created a new, highly detailed method to measure gamma waves. These brain oscillations were once believed to be continuous, resembling the smooth, unbroken rise and fall of a sound wave. However, more recent evidence suggests that gamma activity does not occur in a steady flow but instead appears in short, intermittent bursts.
Building on this concept, the researchers recorded neuronal activity at 16 distinct locations within the visual cortex—the region of the brain responsible for processing visual information. This allowed them to capture both the spatial and temporal dynamics of gamma activity with greater precision. They then separated the recordings into individual gamma events, each representing a single peak-to-trough-to-peak cycle of a wave.
If gamma activity truly behaved like a continuous oscillation, combining all these discrete events would produce a seamless wave pattern moving across the recorded brain regions.
"But it turned out that these events can happen together, or in little bursts, or all by themselves," says Cardin. "They're not happening in a long sequence."
This approach, which the researchers have named CBASS (Clustering Band-limited Activity by State and Spectrotemporal feature), offers a much greater level of sensitivity than other techniques for studying gamma activity.
"It allows us to get very fine timing and to clearly identify these short events, which means we can map them with great precision during interesting moments, like when an animal is making a decision," says Cardin. "That means we can map the events in the brain to the behavior of the animal with more precision than we've ever had before."
When it comes to where gamma activity arises, there have been two schools of thought. A lot of the available evidence has supported the idea that gamma activity is generated in the cortex. But some research has suggested the cortex inherits the activity from elsewhere in the brain—for example, from the thalamus, which sends a lot of sensory and motor information to the cortex.
"With this new method, our data suggest both are wrong, and that this activity arises due to an interaction between the thalamus and the cortex. Gamma arises dynamically as the thalamus sends input to the cortex, where it's then amplified," says Cardin.
Disrupting signals from the thalamus affects behavior
The precision of CBASS also gives the researchers that much-sought-after ability to break the system, to disrupt these patterns of activity in a way that doesn't affect the entire brain.
To do that, the researchers first trained mice on a visual task wherein the mice received a reward if they licked a waterspout only when a certain visual stimulus was shown. Then, the researchers disrupted the signals that the thalamus sent to the cortex, which, in turn, disrupted the gamma activity in the cortex.
This gamma disruption caused the mice to perform much worse on the visual task. So then the researchers took the opposite approach and artificially initiated gamma activity.
"We recorded gamma activity from mice who were detecting the visual stimulus and then played it back into the brain of other mice. And when we did that, it tricked the mice into thinking they had detected a stimulus," says Cardin.
Together, the findings indicate that gamma activity in the cortex supports the integration of visual information and is involved in the behavioral responses that emerge from that integration. And this is important information to have, as studies have shown that this type of activity is altered in people with neurodevelopmental disorders, schizophrenia, and bipolar disorder, as well as neurodegenerative diseases.
Future directions: linking gamma activity to disease and cognition
Cardin's lab is now looking into whether gamma activity in the cortex could be used as an early biomarker for conditions like Alzheimer's disease. Acetylcholine and norepinephrine, key signaling molecules in the thalamus and cortex, are tightly linked to cognition and lost in neurodegenerative diseases. These neuromodulatory signals are known to regulate the pattern of brain activity.
"We're starting to look at how neuromodulatory signals are associated with these gamma events and we'll apply our tools to better understand the sequence of things that go wrong in neurodegeneration," says Cardin. "This could lead to an interpretable early biomarker for Alzheimer's disease that is easily accessible in humans."
Reference: "Flexible perceptual encoding by discrete gamma events" by Quentin Perrenoud, Antonio H. de O. Fonseca, Austin Airhart, James Bonanno, Rong Mao and Jessica A. Cardin, 8 October 2025, Nature.
DOI: 10.1038/s41586-025-09604-9
The researched reported in this news article was supported by the National Institutes of Health (awards EY022951, EY035127, MH113852, and EY026878) and Yale University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional support was provided by the McKnight Foundation, the Kavli Institute of Neuroscience, and the Brain and Behavior Research Foundation.
News
A Simple Brain Scan May Help Restore Movement After Paralysis
A brain cap and smart algorithms may one day help paralyzed patients turn thought into movement—no surgery required. People with spinal cord injuries often experience partial or complete loss of movement in their arms [...]
Plant Discovery Could Transform How Medicines Are Made
Scientists have uncovered an unexpected way plants make powerful chemicals, revealing hidden biological connections that could transform how medicines are discovered and produced. Plants produce protective chemicals called alkaloids as part of their natural [...]
Scientists Develop IV Therapy That Repairs the Brain After Stroke
New nanomaterial passes the blood-brain barrier to reduce damaging inflammation after the most common form of stroke. When someone experiences a stroke, doctors must quickly restore blood flow to the brain to prevent death. [...]
Analyzing Darwin’s specimens without opening 200-year-old jars
Scientists have successfully analyzed Charles Darwin's original specimens from his HMS Beagle voyage (1831 to 1836) to the Galapagos Islands. Remarkably, the specimens have been analyzed without opening their 200-year-old preservation jars. Examining 46 [...]
Scientists discover natural ‘brake’ that could stop harmful inflammation
Researchers at University College London (UCL) have uncovered a key mechanism that helps the body switch off inflammation—a breakthrough that could lead to new treatments for chronic diseases affecting millions worldwide. Inflammation is the [...]
A Forgotten Molecule Could Revive Failing Antifungal Drugs and Save Millions of Lives
Scientists have uncovered a way to make existing antifungal drugs work again against deadly, drug-resistant fungi. Fungal infections claim millions of lives worldwide each year, and current medical treatments are failing to keep pace. [...]
Scientists Trap Thyme’s Healing Power in Tiny Capsules
A new micro-encapsulation breakthrough could turn thyme’s powerful health benefits into safer, smarter nanodoses. Thyme extract is often praised for its wide range of health benefits, giving it a reputation as a natural medicinal [...]
Scientists Develop Spray-On Powder That Instantly Seals Life-Threatening Wounds
KAIST scientists have created a fast-acting, stable powder hemostat that stops bleeding in one second and could significantly improve survival in combat and emergency medicine. Severe blood loss remains the primary cause of death from [...]
Oceans Are Struggling To Absorb Carbon As Microplastics Flood Their Waters
New research points to an unexpected way plastic pollution may be influencing Earth’s climate system. A recent study suggests that microscopic plastic pollution is reducing the ocean’s capacity to take in carbon dioxide, a [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from Frank Boehm
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
New Book! NanoMedical Brain/Cloud Interface – Explorations and Implications
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
Miller School Researchers Pioneer Nanovanilloid-Based Brain Cooling for Traumatic Injury
A multidisciplinary team at the University of Miami Miller School of Medicine has developed a breakthrough nanodrug platform that may prove beneficial for rapid, targeted therapeutic hypothermia after traumatic brain injury (TBI). Their work, published in ACS [...]
COVID-19 still claims more than 100,000 US lives each year
Centers for Disease Control and Prevention researchers report national estimates of 43.6 million COVID-19-associated illnesses and 101,300 deaths in the US during October 2022 to September 2023, plus 33.0 million illnesses and 100,800 deaths [...]
Nanomedicine in 2026: Experts Predict the Year Ahead
Progress in nanomedicine is almost as fast as the science is small. Over the last year, we've seen an abundance of headlines covering medical R&D at the nanoscale: polymer-coated nanoparticles targeting ovarian cancer, Albumin recruiting nanoparticles for [...]
Lipid nanoparticles could unlock access for millions of autoimmune patients
Capstan Therapeutics scientists demonstrate that lipid nanoparticles can engineer CAR T cells within the body without laboratory cell manufacturing and ex vivo expansion. The method using targeted lipid nanoparticles (tLNPs) is designed to deliver [...]















